293 related articles for article (PubMed ID: 16928724)
1. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?
Rossing P; Parving HH; de Zeeuw D
Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724
[No Abstract] [Full Text] [Related]
2. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be?
Hollenberg NK; Epstein M
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325
[No Abstract] [Full Text] [Related]
3. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
4. Effects of renin-angiotensin system blockers on renal outcomes and all-cause mortality in patients with diabetic nephropathy: an updated meta-analysis.
Sarafidis PA; Stafylas PC; Kanaki AI; Lasaridis AN
Am J Hypertens; 2008 Aug; 21(8):922-9. PubMed ID: 18535536
[TBL] [Abstract][Full Text] [Related]
5. Treating diabetic nephropathy: unfinished success is not failure.
Lewis J
Clin J Am Soc Nephrol; 2007 May; 2(3):407-9. PubMed ID: 17699442
[No Abstract] [Full Text] [Related]
6. [RAS blockade in diabetic nephropathy. "Early intervention can dramatically decrease loss of function].
Ritz E
MMW Fortschr Med; 2004 Sep; 146(38):12. PubMed ID: 15532423
[No Abstract] [Full Text] [Related]
7. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
de Zeeuw D
Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
[TBL] [Abstract][Full Text] [Related]
8. Renin angiotensin system (RAS) blockade and diabetic microvascular complications in the eye and kidney.
Bilous R
Prim Care Diabetes; 2008 Dec; 2(4):201-2. PubMed ID: 18760685
[No Abstract] [Full Text] [Related]
9. Toward better renoprotection: lessons from angiotensin receptor blockers.
Miyata T; Takizawa S
Hemodial Int; 2007 Apr; 11(2):164-8. PubMed ID: 17403166
[TBL] [Abstract][Full Text] [Related]
10. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
Hirsch S
Int J Clin Pract; 2010 Sep; 64(10):1337-40. PubMed ID: 20716140
[No Abstract] [Full Text] [Related]
11. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Katavetin P; Katavetin P
N Engl J Med; 2009 Oct; 361(14):1410-1; author reply 1411. PubMed ID: 19802919
[No Abstract] [Full Text] [Related]
12. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
Fronczyk A; Majkowska L
Przegl Lek; 2007; 64(2):81-5. PubMed ID: 17892038
[TBL] [Abstract][Full Text] [Related]
13. Rationale for combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor treatment and end-organ protection in patients with chronic kidney disease.
Toto R; Palmer BF
Am J Nephrol; 2008; 28(3):372-80. PubMed ID: 18073461
[TBL] [Abstract][Full Text] [Related]
14. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.
Jimenez J; Safranek S; Viera AJ
Am Fam Physician; 2007 Aug; 76(3):423-4. PubMed ID: 17708144
[No Abstract] [Full Text] [Related]
15. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
16. Maximizing inhibition of the renin-angiotensin system with high doses of converting enzyme inhibitors or angiotensin receptor blockers.
Berl T
Nephrol Dial Transplant; 2008 Aug; 23(8):2443-7. PubMed ID: 18467376
[No Abstract] [Full Text] [Related]
17. Progression of renal disease--can we forget about inhibition of the renin-angiotensin system?
Mann JF; McClellan WM; Kunz R; Ritz E
Nephrol Dial Transplant; 2006 Sep; 21(9):2348-51; discussion 2352-3. PubMed ID: 16822789
[No Abstract] [Full Text] [Related]
18. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
Wittmann I; Degrell P; Komáromy A; Molnár GA; Wagner Z; Wagner L; Mazák I; Nagy J
Orv Hetil; 2003 Mar; 144(13):613-9. PubMed ID: 12728786
[TBL] [Abstract][Full Text] [Related]
19. Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Tamsma JT
N Engl J Med; 2009 Oct; 361(14):1410; author reply 1411. PubMed ID: 19797291
[No Abstract] [Full Text] [Related]
20. [Renoprotection and blockade of the renin-angiotensin system: What shall we believe?].
Kamper AL; Feldt-Rasmussen B; Strandgaard S
Ugeskr Laeger; 2006 Apr; 168(15):1563. PubMed ID: 16640988
[No Abstract] [Full Text] [Related]
[Next] [New Search]
